MedPath

Acute Exacerbation of Chronic Obstructive Pulmonary Disease Inpatient Registry Study

Conditions
Chronic Obstructive Pulmonary Disease
Registration Number
NCT02657525
Lead Sponsor
China-Japan Friendship Hospital
Brief Summary

The purpose of this study is to investigate the demographic characteristics, clinical features, diagnoses and treatments of AECOPD hospitalized patients in China, and disease prognosis and its economic burden.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
7600
Inclusion Criteria

≥18 years of age; hospitalized patients with main diagnosis as AECOPD.

Exclusion Criteria

Patients diagnosed as active pulmonary tuberculosis, or acute left heart failure; Patients participating in clinical trials or intervention studies of drugs.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
In-hospital mortality12 months

All-cause and cause-specific mortality will be described.

Readmission12 months

Readmission rate caused by AECOPD within 1 month after discharged from hospital.

Secondary Outcome Measures
NameTimeMethod
All-cause and cause-specific mortality3 years

All-cause and cause-specific mortality will be described at different time points (1, 2, 3 years)

Recurrence of acute exacerbation of COPD3 years

Frequency of AECOPD recurrence will be described during follow-ups, the date of first recurrence after discharge will be analysed.

Lung function and quality of life assessment3 years

Lung function will be measured regularly, quality of life will be assessed by questionnaires

Healthcare costs12 months

Direct costs of hospital stay will be recorded.

© Copyright 2025. All Rights Reserved by MedPath